¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå(2024-2028³â)
Global protein therapeutics market 2024-2028
»óǰÄÚµå : 1502129
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 191 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Technavio´Â ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, 2023-2028³â¿¡ 1,728¾ï ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 9.47%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. MABS¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡, Çõ½ÅÀû ±â¼úÀ» ÀÌ¿ëÇÑ ½Å±Ô ¿ä¹ýÀÇ °³¹ß, À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÇ ÀÌ¿ë °¡´É¼º µîÀÌ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024
Á¾·á³â 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2024³â 8.44%
CAGR 9.47%
ÁõºÐ¾× 1,728¾ï ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¼ö³â°£ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ Çϳª·Î ´Ü¹éÁú Ä¡·áÁ¦ÀÇ °³·®¿¡ ´ëÇÑ Áö¼ÓÀû ÁÖ·ÂÀ» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌÁ߯¯À̼ºÇ×ü ¹× ´ÙƯÀ̼º Ç×üÀÇ ÃâÇöÀ̳ª ¸¸¼ºÁúȯÀÇ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ±¸µµ

Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦8Àå °í°´ »óȲ

Á¦9Àå Áö¿ªº° »óȲ

Á¦10Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå °æÀï ºÐ¼®

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Technavio has been monitoring the protein therapeutics market and is forecast to grow by USD 172.8 bn during 2023-2028, accelerating at a CAGR of 9.47% during the forecast period. Our report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for MABS, development of novel therapies using innovative technologies, and availability of favorable reimbursement policies.

Technavio's protein therapeutics market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20248.44%
CAGR9.47%
Incremental Value$172.8bn

By Product

By Application

By Geography

This study identifies the continued focus on improvement of protein therapeutics as one of the prime reasons driving the protein therapeutics market growth during the next few years. Also, emergence of bi-specific and multi-specific antibodies and increase in chronic diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the protein therapeutics market covers the following areas:

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc., PV Pharma Healthcare Pvt. Ltd., and Sanofi SA. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by Application

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â